Bluejay Diagnostics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.3M | $-1.9M | $-1.4M | $-1.6M | $-2.0M | $-1.9M | $-1.4M | $-1.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $28.2K | $27.8K | $27.4K | $10.6K | $17.7K | $18.4K | $19.8K | $17.7K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $74 | $183 | $-1.6K | $1.3K | $-2.6K | $4.8K |
| Net Cash from Operating Activities | $-1.5M | $-1.6M | $-1.5M | $-1.4M | $-2.1M | $-1.2M | $-1.5M | $-2.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $142.8K | $19.0K | — | — | — | — | $1.1K | $227 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-142.8K | $-15.3K | — | — | — | — | $-1.1K | $-227 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $7.6M | $124.1K | $3.7M | $-1.0K | $3.4M | $-985 | $-1.3K | $-147.9K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-1.6M | $-1.6M | — | — | — | — | $-1.5M | $-2.2M |